Mortality and Cardiovascular Risk Associated With Different Insulin Secretagogues Compared With Metformin in Type 2 Diabetes, With or Without a Previous Myocardial Infarction: A Nationwide Study

Study Questions:

What is the impact of insulin secretagogues (ISs) on long-term major clinical outcomes in type 2 diabetes?